TAMMY PESARESI: Open Payments
NPI 1255660734 · NIAGARA FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 33 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $390 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 4 | $192 |
| Teva Pharmaceuticals USA, Inc. | 10 | $151 |
| Lilly USA, LLC | 5 | $125 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Lundbeck LLC | 3 | $65 |
| Pharmacosmos Therapeutics Inc. | 2 | $64 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| PFIZER INC. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: Leqembi, REXULTI, AUSTEDO XR, KISUNLA, MONOFERRIC, INGREZZA, NURTEC ODT, CAPLYTA.
Industry payments across NY — which companies pay providers there.
